AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Hansa Biopharma AB (publ)

$3.29 +$0.38 (+13.02%)
OTC · 30 Oct 2026 20:00 UTC
Previous Close
$3.29
Day Range
$2.93$3.29
Year Range
$2.90$4.58
Market Cap
328.02M
AVG Volume
318
Trailing/Forward PE
-5.01/-
PEG ratio
0.05
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
Other OTCUS
Revenue (SEK) · TTM
0100M200M300M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HNSBF Revenue (SEK) by quarter, trailing twelve months
PeriodRevenue (SEK)
26 Q2189.13M
26 Q1190.16M
25 Q4222.05M
25 Q3178.4M
25 Q2196.47M
25 Q1181.68M
24 Q4171.32M
24 Q3189.39M
24 Q2163.56M
24 Q1165.88M
Net Income (SEK) · TTM
-1B-750M-500M-250M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HNSBF Net Income (SEK) by quarter, trailing twelve months
PeriodNet Income (SEK)
26 Q2-768.23M
26 Q1-686.58M
25 Q4-528M
25 Q3-639.38M
25 Q2-596.17M
25 Q1-625.24M
24 Q4-806.74M
24 Q3-654.78M
24 Q2-801.64M
24 Q1-844.88M
Operating Income (SEK) · TTM
-800M-600M-400M-200M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HNSBF Operating Income (SEK) by quarter, trailing twelve months
PeriodOperating Income (SEK)
26 Q2-587.6M
26 Q1-568.28M
25 Q4-520.07M
25 Q3-538.79M
25 Q2-508.72M
25 Q1-535.66M
24 Q4-595.14M
24 Q3-633.46M
24 Q2-718.68M
24 Q1-765.46M
EBITDA · TTM
Cash Flows · TTM
EPS · TTM
Expenses · TTM
Cash & Debt · TTM
Debt ratios · TTM
Margins · TTM
Return on Capital · TTM
Shares Outstanding · TTM
Dividends (SEK) · TTM
Employee Count
Book Value Per Share · TTM
Total Assets · TTM
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book

Earnings: HNSBF

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 11 Nov 2026.

Hansa Biopharma AB (publ)
HNSBF
Stockpicker

Video analysis: HNSBF

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HNSBF

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.